Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-126045
Filing Date
2016-06-06
Accepted
2016-06-06 17:27:13
Documents
2
Period of Report
2016-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4121
2 POA DOCUMENT poa.txt EX-24.4_660190 1552
  Complete submission text file 0001209191-16-126045.txt   7421
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Issuer) CIK: 0001016169 (see all company filings)

EIN.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O INKINE PHARMACEUTICAL COMPANY INC 425 PARK AVENUE NEW YORK NY 10022
Business Address
JACOB LEONARD S (Reporting) CIK: 0001049713 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 0630
Type: 4 | Act: 34 | File No.: 001-32302 | Film No.: 161699418